HUTCHMED (China) (HCM) Gains from Investment Securities (2020 - 2021)
HUTCHMED (China)'s (HCM) quarterly Gains from Investment Securities came in at $30.5 million in Q1 2021, up 7.93% year-on-year from $28.3 million in Q1 2020, and up 7.93% on a QoQ basis from $28.3 million in Q1 2020.
HUTCHMED (China) (HCM) Gains from Investment Securities (2020 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 2 years of Gains from Investment Securities data on file, last reported at $30.5 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn |
| 3 | Zoetis | 32.55 Bn | 30.61 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 9.57 Bn | 9.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 30.51 Mn |
| Mar 31, 2021 | 30.51 Mn |
| Mar 31, 2020 | 28.27 Mn |
| Mar 31, 2020 | 28.27 Mn |